These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3501214)

  • 1. Abstracts of the symposium on hypertension and the ageing cardiovascular system: the role of serotonin. Brussels, February 7, 1987.
    Acta Cardiol; 1987; 42(5):321-75. PubMed ID: 3501214
    [No Abstract]   [Full Text] [Related]  

  • 2. Symposium on serotonin and cardiovascular regulation: a new approach to hypertension. Satellite symposium of the Second European Meeting on Hypertension. 9 June 1985, Milan, Italy.
    J Hypertens Suppl; 1986 Apr; 4(1):S1-111. PubMed ID: 2939207
    [No Abstract]   [Full Text] [Related]  

  • 3. [Serotonin and cardiovascular regulation: new aspects of hypertension. Satellite symposium of the Second European Meeting on Hypertension. Milan, 9 June 1985].
    Med Klin Suppl; 1985; 1():1-16. PubMed ID: 3870421
    [No Abstract]   [Full Text] [Related]  

  • 4. Renal hemodynamic effects of ketanserin therapy in essential hypertension.
    Ram CV; Gonzalez DG; Kaplan NM; Ralakis JM; Henderson JD; Lugo CE; Zachariah N
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S78-80. PubMed ID: 2446078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ageing, and treatment of hypertension.
    Robertson JI
    Drugs; 1988; 36 Suppl 1():1-6. PubMed ID: 3071455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of ketanserin on systemic and regional haemodynamics in patients with essential hypertension.
    Ito Y; Isaka M; Noda H; Sato Y; Fujita T
    Drugs; 1988; 36 Suppl 1():120-2. PubMed ID: 3240725
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical application of serotonin antagonists in the treatment of hypertension].
    Deguchi F; Saito T; Inagaki Y
    Nihon Rinsho; 1989 Sep; 47(9):2058-63. PubMed ID: 2593279
    [No Abstract]   [Full Text] [Related]  

  • 8. Serotonin: receptors and antagonists--summary of symposium.
    Prichard BN; Smith CC
    Clin Physiol Biochem; 1990; 8 Suppl 3():120-8. PubMed ID: 2132173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ketanserin: a possible tool for studying the role of serotonin in hypertension.
    Woittiez AJ; Wenting GJ; Man in't Veld AJ; Boomsma F; Schalekamp MA
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S130-6. PubMed ID: 2412035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin and preactivated platelets in essential hypertension.
    Bühler FR; Amstein R; Fetkovska N
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S32-4. PubMed ID: 2446066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Why are the antihypertensive effects of ketanserin age-related?
    Doyle AE
    J Cardiovasc Pharmacol; 1988; 12 Suppl 8():S124-31. PubMed ID: 2469894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of alpha-adrenergic blockade in the cardiovascular actions of ketanserin: studies in patients with essential hypertension, autonomic insufficiency, and Raynaud's phenomenon.
    Brouwer RM; Wenting GJ; Man in't Veld AJ; Schalekamp MA
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S26-31. PubMed ID: 2446064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of serotonin and its receptors in the pathogenesis of arterial hypertension].
    Belousov IuB; Krivonkin KIu
    Kardiologiia; 1992; 32(11-12):5-9. PubMed ID: 1297881
    [No Abstract]   [Full Text] [Related]  

  • 14. [Serotonin and its physiological and pathophysiological roles. Ketanserin].
    Metelitsa TV
    Kardiologiia; 1989 Sep; 29(9):120-5. PubMed ID: 2687555
    [No Abstract]   [Full Text] [Related]  

  • 15. Ketanserin: a selective serotonin antagonist.
    Lancet; 1982 Oct; 2(8303):859. PubMed ID: 6126719
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effects of ketanserin on glucose metabolism in hypertensive diabetic subjects].
    Carleo R; Gobbo M; Bonavita M; De Matteo A; Gallo M; Gatti A
    Boll Soc Ital Biol Sper; 1990 Jul; 66(7):639-46. PubMed ID: 1964564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Specific aspects of the action of serotonin and ketanserin in the regulation of arterial pressure].
    Wellens D
    Rev Med Liege; 1988 Mar; 43 Suppl 1():34-7. PubMed ID: 3375649
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cardiovascular pharmacology of serotonin and its antagonists].
    Van Nueten JM
    Rev Med Liege; 1988 Mar; 43 Suppl 1():22-30. PubMed ID: 3287545
    [No Abstract]   [Full Text] [Related]  

  • 19. The rationale for ketanserin therapy in hypertension.
    Hansson L; Hedner T
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S39-44. PubMed ID: 2446068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serotonin and cardiovascular diseases. Pathophysiology and significance of serotonin antagonists].
    Lüscher TF; Tanner FC; Bühler FR
    Dtsch Med Wochenschr; 1992 Apr; 117(18):710-9. PubMed ID: 1572260
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.